Phospholipase A2 Group IIA Is Associated with Inflammatory Hepatocellular Adenoma
- PMID: 38201587
- PMCID: PMC10778238
- DOI: 10.3390/cancers16010159
Phospholipase A2 Group IIA Is Associated with Inflammatory Hepatocellular Adenoma
Abstract
Although benign hepatocellular adenomas (HCA) are very rare, recent observations have shown their occurrence in patients with diabetes mellitus. Consequently, most of these cases are treated by resection due to concerns regarding their potential progression to hepatocarcinoma (HCC). This decision is largely driven by the limited number of studies on HCC subtyping and the lack of molecular and biological insights into the carcinogenic potential of benign tumors. This study aimed to comprehensively investigate the subtype classification of HCA and to compare and analyze gene expression profiling between HCA and HCC tissues. One fresh inflammatory HCA (I-HCA), three non-B non-C HCCs, two hepatitis B virus-HCCs, and one normal liver tissue sample were subjected to single-cell RNA sequencing (scRNA-seq). Comparative analysis of scRNA-seq among different tissues showed that phospholipase A2 group IIA (PLA2G2A) mRNA was specifically expressed in I-HCA, following RNA-seq analysis in formalin-fixed paraffin-embedded tissues from other HCAs. Immunohistochemistry using the PLA2G2A antibody in these tissues indicated that the positive reaction was mainly observed in hepatocytes of I-HCAs and stromal cells surrounding the tumor tissue in HCC were also stained. According to a clinical database, PLA2G2A expression in HCC does not correlate with poor prognosis. This finding may potentially help develop a new definition for I-HCA, resulting in a significant clinical contribution, but it requires validation with other fresh HCA samples.
Keywords: Pla2g2a; hepatocellular adenoma; hepatocellular carcinoma; single-cell RNA sequencing.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures






Similar articles
-
Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.Lipids Health Dis. 2017 Jan 11;16(1):5. doi: 10.1186/s12944-016-0400-7. Lipids Health Dis. 2017. PMID: 28077172 Free PMC article.
-
Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features.Histopathology. 2023 Apr;82(5):722-730. doi: 10.1111/his.14858. Epub 2023 Jan 25. Histopathology. 2023. PMID: 36583256
-
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.Gastroenterology. 2017 Mar;152(4):880-894.e6. doi: 10.1053/j.gastro.2016.11.042. Epub 2016 Dec 7. Gastroenterology. 2017. PMID: 27939373
-
Hepatocellular adenomas: review of pathological and molecular features.Hum Pathol. 2021 Jun;112:128-137. doi: 10.1016/j.humpath.2020.11.016. Epub 2020 Dec 9. Hum Pathol. 2021. PMID: 33307077 Review.
-
Myxoid hepatocellular adenoma, a rare variant of hepatocellular adenoma with distinct imaging features: A case report with immunohistochemical and molecular analysis and literature review.Clin Res Hepatol Gastroenterol. 2021 May;45(3):101478. doi: 10.1016/j.clinre.2020.06.004. Epub 2020 Jun 30. Clin Res Hepatol Gastroenterol. 2021. PMID: 32620388 Review.
Cited by
-
Multi-omics analysis deciphers intercellular communication regulating oxidative stress to promote oral squamous cell carcinoma progression.NPJ Precis Oncol. 2024 Nov 21;8(1):272. doi: 10.1038/s41698-024-00764-x. NPJ Precis Oncol. 2024. PMID: 39572698 Free PMC article.
References
-
- Nault J.C., Couchy G., Balabaud C., Morcrette G., Caruso S., Blanc J.F., Bacq Y., Calderaro J., Paradis V., Ramos J., et al. Molecular Classification of Hepatocellular Adenoma Associates with Risk Factors, Bleeding, and Malignant Transformation. Gastroenterology. 2017;152:880–894.e6. doi: 10.1053/j.gastro.2016.11.042. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources